Memorial Sloan Kettering Cancer Center
ASCO 2022 on the Phase 3 KEYNOTE-522 Trial: TNBC Updates
By
Nebraska Oncology Society
FEATURING
Chau Dang
By
Nebraska Oncology Society
FEATURING
Chau Dang
Login to view comments.
Click here to Login